Comparing blood purification methods in children with sepsis

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational study investigates the effects of continuous blood purification (CBP) in children diagnosed with sepsis or septic shock. It aims to explore the efficacy of CBP and the optimal timing for its application to improve patient outcomes. By removing inflammatory factors and enhancing immune response, the study seeks to determine how early intervention with CBP can mitigate organ damage and restore immune balance in affected children.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* Age of 29d to 18 years old;
* Children diagnosed with sepsis requiring blood purification.

Exclusion Criteria:

* with a history of a duration of PICU stay \<24 h
* active bleeding, including cerebral hemorrhage

Where it's running

• Children'S Hospital of Fudan University
  Shanghai, Shanghai Municipality, China Recruiting

Study contacts

• Principal investigator: Lu guoing — Children's Hospital of Fudan University
• Study coordinator: Ying Jiayun
• Email: jiayundoctor@163.com
• Phone: 18817583962

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Investigating long-term effects of sepsis in critically ill children

  This study looks at how sepsis affects critically ill children over five years to see how it impacts their growth, brain development, survival, and quality of life after leaving the hospital.

  Recruiting West China Hospital · Chengdu, Sichuan · NCT06323226

• Ruta C and Vitamin C in Sepsis: Adding antioxidants to standard care

  This trial tests whether adding Ruta C (rutin plus vitamin C) or vitamin C alone to standard sepsis treatment helps adults in the ICU stay shorter and recover better.

  Recruiting Ain Shams University · Cairo, Cairo Governorate · NCT07922213

• Early detection of sepsis-related blood clotting problems in severe burn patients

  This study tests how well the JAAM-2 score can detect sepsis-induced coagulopathy early in adults with severe burns who develop sepsis in the ICU.

  Recruiting Center for Traumatology and Major Burns, Ben Arous · Tunis · NCT07914205

• Neutrophil EMR3 as a biomarker for sepsis in ICU patients

  Researchers will test whether measuring EMR3 on neutrophils helps diagnose sepsis, monitor progression, and predict outcomes in adults in Chinese ICUs.

  Recruiting Sir Run Run Shaw Hospital · Hangzhou, Zhejiang · NCT07896018

• Thymalfasin added to standard care for adults with sepsis and immune dysfunction

  This study tests whether thymosin alpha-1 helps restore immune function in adults with sepsis who have weakened immunity.

  Recruiting Shanghai Zhongshan Hospital · Shanghai, Shanghai Municipality · NCT07866118

• Multicenter group study of sepsis and ARDS in China

  This study tests how sepsis and ARDS differ among adults across several Chinese hospitals and builds a biobank to understand why some patients do better or worse.

  Recruiting at 24 sites Shanghai Zhongshan Hospital · Xiamen, Fujian and 23 other locations · NCT07863908

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.